Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis
about
Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapyThe serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigensImmediate determination of ACPA and rheumatoid factor--a novel point of care test for detection of anti-MCV antibodies and rheumatoid factor using a lateral-flow immunoassayRole of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis.Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis.Laboratory biomarkers or imaging in the diagnostics of rheumatoid arthritis?A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritisHigher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgarisAnti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis.The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis.Effect of nonsurgical periodontal treatment in patients with periodontitis and rheumatoid arthritis: A systematic review.Cross-reactivity of a human IgG₁ anticitrullinated fibrinogen monoclonal antibody to a citrullinated profilaggrin peptide.
P2860
Q21195370-67807C62-BA42-403D-A50D-209E61D9FCD8Q24646963-12F8A06E-64CE-4301-9DAB-5DFC4342B61FQ34027640-DD344939-9C70-42C1-B00C-757948026912Q34250833-4863A8B0-002D-43FC-BD21-EC8CF8189DCCQ34700316-F6DD833E-D44D-4DB5-A2F3-8F9CCE7D8FF0Q35123760-A3C77CA4-3559-4F1E-A848-287EBC2676FFQ35207886-250FB8BE-7AD9-4A54-9EAF-75D4B03DE946Q36733774-41B502A2-EFA5-46F5-B88E-A99EE50F6956Q37624583-5DC98E09-A53C-4B5B-B612-D8EBAE42DCEFQ37710782-B67340A4-8018-4A0E-A2D0-7970655AE905Q37833378-6F3C6662-FE5F-4AC5-8A0E-16CD1D344EF2Q38762138-8ABC05B0-2F70-4E3F-B670-B7C4479F3F8BQ43225831-635D23EA-47F1-4D1D-9C98-0B812EB98DD5
P2860
Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Clinical evaluation of anti-mu ...... ELISA in rheumatoid arthritis
@ast
Clinical evaluation of anti-mu ...... ELISA in rheumatoid arthritis
@en
Clinical evaluation of anti-mu ...... ELISA in rheumatoid arthritis
@nl
type
label
Clinical evaluation of anti-mu ...... ELISA in rheumatoid arthritis
@ast
Clinical evaluation of anti-mu ...... ELISA in rheumatoid arthritis
@en
Clinical evaluation of anti-mu ...... ELISA in rheumatoid arthritis
@nl
prefLabel
Clinical evaluation of anti-mu ...... ELISA in rheumatoid arthritis
@ast
Clinical evaluation of anti-mu ...... ELISA in rheumatoid arthritis
@en
Clinical evaluation of anti-mu ...... ELISA in rheumatoid arthritis
@nl
P2093
P1476
Clinical evaluation of anti-mu ...... ELISA in rheumatoid arthritis
@en
P2093
Andrea Fekete
Anikó Kapitány
Anikó Végvári
Gabriella Lakos
Gyula Szegedi
Ildikó F Horváth
Katalin Dankó
Lilla Soós
Margit Zeher
Sandor Sipka
P304
P407
P577
2007-07-01T00:00:00Z